Search over 3,000 reports

    Pruritus - Pipeline Insights, 2017

    Pruritus - Pipeline Insights, 2017
    Date: Nov, 2017
    Type: Pharmaceutical Industry Report
    Pages: 108
    Geography: Global
    Delivery Timeline: 24 Hours
    SKU: DIPI0141
    DelveInsight's, "Pruritus - Pipeline Insights, 2017", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall underPruritus. This report provides information on the therapeutic development for Pruritus dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the company's information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
    Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
    Pruritus Overview
    Pipeline Therapeutics
    Therapeutics under Development by Companies
    Last Stage Products (Phase III)
    Mid Stage Products (Phase II)
    Early StageProducts (Phase I)
    Pre-clinical stage Products
    Therapeutic Assessment
    Assessment by Monotherapy Products
    Assessment by Route of Administration
    Assessment by Stage and Route of Administration
    Assessment by Molecule Type
    Assessment by Stage and Molecule Type
    Discontinued Products
    Dormant Products
    Companies Involved in Therapeutics Development
    Consulting Services
    About DelveInsight
    Contact Us
    Table 1:Number of Products Under Development for Pruritus
    Table 2: Number of Products under Development by Companies
    Table 3: Last Stage Products (Phase III)
    Table 4: Mid Stage Products (Phase II
    Table 5: Early Stage Products (Phase I)
    Table 6: Discovery and Pre-clinical Stage Products
    Table 7: Assessment by Monotherapy Products
    Table 8: Assessment by Route Of Administration
    Table 9:Assessment by Stage and Route Of Administration
    Table 10: Assessment by Molecule Type
    Table 11: Assessment by Stage and Molecule Type
    Table 12: Discontinued Products
    Table 13:Dormant Products
    Table 14: Albireo Pharma Inc., Overview
    Table 15: Amorepacific Corporation , Overview
    Table 16:Asana BioSciences LLC , Overview
    Table 17:Chong Kun Dang Pharmaceuticals , Overview
    Table Continued?
    Table 31:Vanda Pharmaceutical Inc., Overview
    Figure 1: Pruritus (itch)
    Figure 2: Pathophysiology of Pruritus
    Figure 3: Diagnosis Algorithm for Pruritus
    Figure 4: Number of Products under Development for Pruritus
    Figure 5: Last Stage Products (Phase III)
    Figure 6: Mid Stage Products (Phase II)
    Figure 7: Early Stage Products (Phase I)
    Figure 8: Pre-clinical Stage Products,2017
    Figure 9: Assessment by Monotherapy Products
    Figure 10: Assessment by Route of Administration
    Figure 11: Assessment by Stage and Route of Administration
    Figure 12: Assessment by Molecule Type
    Figure 13: Assessment by Stage and Molecule Type
    Figure 14:Discontinued Products
    Figure 15: Dormant Products
    Pruritus Pipeline Drugs

    Pruritus Pipeline Assessment

    Pruritus Pipeline Analysis

    Pruritus Drugs under Development

    Pruritus Discovery drugs

    Pruritus Preclinical drugs

    Pruritus Phase I drugs

    Pruritus Phase II drugs

    Pruritus Phase III Pipeline Drugs Assessment

    Pruritus Preregistration drugs

    Pruritus Molecules in pipeline

    • Single User License
      (20% Off)
    • Site License
      (30% Off)
    • Global License
      (40% Off)

    Contact Us

    +91-11-45689769, +91 9650213330


    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap